C. Solomon et al., The unique tryptophan residue of the vitamin D receptor is critical for ligand binding and transcriptional activation, J BONE MIN, 16(1), 2001, pp. 39-45
The human vitamin D receptor (hVDR) is a member of the nuclear receptor sup
erfamily of transcriptional regulators, Here we show that tryptophan 286 of
the hVDR Is critical for ligand binding and transactivation of 1,25-dihydr
oxyvitamin D-3 [1,25(OH)(2)D-3] target genes. Two mutants of the hVDR were
produced, W286A and W286F, in which the tryptophan was replaced with an ala
nine or a phenylalanine, respectively. The W286A mutant did not bind 1,25(O
H)2D3, interact with steroid receptor coactivator 1 (SRC-1) in vitro, or ac
tivate transcription. Moreover, the W286A receptor did not heterodimerize i
n a ligand-dependent manner with the human retinoid X receptor alpha (hRXR
alpha). Although the W286F receptor heterodimerized with hRXR alpha, intera
cted with SRC-1, and bound 1,25(OH)(2)D-3 its capacity to transactivate was
attenuated severely. Thus, tryptophan 286 of hVDR plays an important role
in specific 1,25(OH)(2)D-3 ligand interaction and subsequently in hVDR/RXR
interaction, SRC-1 binding, and ligand-dependent transactivation of 1,25(OH
)(2)D-3 target genes, These results identify the first amino acid that is a
bsolutely required for ligand binding in the VDR and further define the str
ucture-function relationship of 1,25(OH)(2)D-3 interaction with its recepto
r.